Please ensure Javascript is enabled for purposes of website accessibility
IpsiHand is the only FDA-cleared, non-invasive treatment of stroke. See if you qualify →
neurolutions logo
Do I Qualify?

Form Pop Up

by | Mar 5, 2024

See if You Qualify id="JotFormIFrame-240427066602046" title="Orthoses Page" onload="window.parent.scrollTo(0,0)" allowtransparency="true" allowfullscreen="true" allow="geolocation; microphone; camera" src="https://form.jotform.com/240427066602046" frameborder="0"...

Calvin Portley

by | Nov 13, 2023

Calvin Portley Calvin Portley has extensive work experience in various roles and industries with much of his time spent in healthcare technology commercialization. Calvin is the Chief Business Officer at Neurolutions, a position he has held since May 2020. Prior to...

Javad Seyedzadeh

by | Nov 13, 2023

Javad Seyedzadeh Javad is a Business Advisor, Corporate Officer, and Senior Executive with an impressive 35-year track record in healthcare leadership. Specializing in imaging, in vitro, and in vivo industries, he has demonstrated unparalleled expertise in Quality...

Andy Schultz

by | Nov 13, 2023

Andy Schultz Andy Schultz is the Chief Commercial Officer of Neurolutions, Inc. Prior to joining Neurolutions, he was SVP of Revenue and Operations at Candid, a disruptor in the orthodontic clear aligner space. Andy spent nearly 5 years at Candid leading and scaling...

Lisa Garrett

by | Nov 13, 2023

Lisa Garrett Lisa Garrett joined Neurolutions in March 2023 and brings over 20 years experience in medical technology companies. Most recently Lisa was the CFO at Cardiva Medical until its acquisition by Haemonetics in 2021. Previously she served as CFO at ForSight...